![Kyle Carver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kyle Carver
Financieel Directeur/CFO bij
EVOMMUNE, INC.
Vermogen: 763 841 $ op 31-08-2026
Profiel
Kyle Carver worked at Kadmon Holdings, Inc. from 2014 to 2022, serving as Chief Accounting Officer & Controller from 2018 to 2022.
Mr. Carver completed undergraduate studies at Villanova University and earned an MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EVOMMUNE, INC. 0,17% | 08-07-2026 | 60.335 ( 0,17% ) | 763 841 $ | 31-08-2026 |
Actieve functies van Kyle Carver
| Bedrijven | Functie | Begin |
|---|---|---|
| EVOMMUNE, INC. | Financieel Directeur/CFO | 01-03-2022 |
Eerdere bekende functies van Kyle Carver
| Bedrijven | Functie | Einde |
|---|---|---|
| KADMON HOLDINGS, INC. | Comptroller/Controller/Auditor | 01-03-2022 |
Opleiding van Kyle Carver
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
40
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
